Quoin Pharmaceuticals Ltd ADR (QNRX): Next-Year EPS Estimate 45.37%
As of 2026-06-04, Quoin Pharmaceuticals Ltd ADR (QNRX) has a next-year EPS growth estimate of 45.37%.
On 2026-05-13, analyst consensus for QNRX's next-year EPS growth shifted from 42.72% to 45.37% — a positive change of 2.65 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at 56.22%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 45.37%
- EPS growth this year
- 56.22%
- EPS next quarter (est)
- -$1.61
- Last price
- $4.29
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 45.37% | 56.22% | -$1.61 | $4.29 |
| 2026-06-03 | 45.37% | 56.22% | -$1.61 | $4.43 |
| 2026-06-02 | 45.37% | 56.22% | -$1.61 | $4.56 |
| 2026-06-01 | 45.37% | 56.22% | -$1.61 | $4.77 |
| 2026-05-31 | 45.37% | 56.22% | -$1.61 | $5.06 |
| 2026-05-28 | 45.37% | 56.22% | -$1.61 | $4.94 |
| 2026-05-27 | 45.37% | 56.22% | -$1.61 | $5.00 |
| 2026-05-26 | 45.37% | 56.22% | -$1.61 | $4.84 |
| 2026-05-25 | 45.37% | 56.22% | -$1.61 | $4.77 |
| 2026-05-24 | 45.37% | 56.22% | -$1.61 | $4.77 |
| 2026-05-21 | 45.37% | 56.22% | -$1.61 | $4.85 |
| 2026-05-20 | 45.37% | 56.22% | -$1.61 | $4.94 |
| 2026-05-19 | 45.37% | 56.22% | -$1.61 | $5.17 |
| 2026-05-18 | 45.37% | 56.22% | -$1.61 | $5.53 |
| 2026-05-17 | 45.37% | 56.22% | -$1.61 | $5.79 |
| 2026-05-14 | 45.37% | 56.22% | -$1.61 | $5.81 |
| 2026-05-13 | 45.37% | 56.22% | -$1.61 | $5.90 |
| 2026-05-12 | 42.72% | 58.24% | -$1.54 | $6.07 |
| 2026-05-11 | 42.72% | 58.24% | -$1.54 | $6.28 |
| 2026-05-10 | 42.72% | 58.24% | -$1.54 | $5.93 |
| 2026-05-07 | 52.75% | 52.14% | -$1.95 | $6.37 |
| 2026-05-06 | 52.75% | 52.14% | -$2.17 | $6.43 |
| 2026-05-05 | 52.75% | 52.14% | -$2.17 | $6.31 |
| 2026-05-04 | 52.75% | 52.14% | -$2.17 | $6.36 |
| 2026-03-26 | 78.27% | N/A | N/A | $7.57 |
| 2026-03-26 | 93.38% | N/A | N/A | $7.57 |
| 2026-03-25 | 78.27% | N/A | N/A | $9.27 |
| 2026-03-25 | 78.27% | N/A | N/A | $9.27 |
| 2026-03-25 | 78.27% | N/A | N/A | $9.27 |
| 2026-03-24 | 78.27% | N/A | N/A | $8.00 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Quoin Pharmaceuticals Ltd ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Quoin Pharmaceuticals Ltd ADR (QNRX) has a next-year EPS growth estimate of 45.37%, based on analyst consensus.
When was the latest EPS estimate revision for QNRX?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 42.72% to 45.37%.
What sector and industry does Quoin Pharmaceuticals Ltd ADR belong to?▾
Quoin Pharmaceuticals Ltd ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. QNRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Quoin Pharmaceuticals Ltd ADR (QNRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports